Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Protein minimization by random fragmentation and selection.

G W Rudgers1, T Palzkill

  • 1Department of Molecular Virology and Microbiology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.

Protein Engineering
|August 28, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification and characterization of beta-lactamase inhibitor protein-II (BLIP-II) interactions with beta-lactamases using phage display.

Protein engineering, design & selection : PEDS·2010
Same author

Identification of residues critical for metallo-beta-lactamase function by codon randomization and selection.

Protein science : a publication of the Protein Society·2001
Same author

Binding properties of a peptide derived from beta-lactamase inhibitory protein.

Antimicrobial agents and chemotherapy·2001
Same author

Amino acid sequence determinants of extended spectrum cephalosporin hydrolysis by the class C P99 beta-lactamase.

The Journal of biological chemistry·2001
Same author

Impending doom: antibiotic exposure and bacterial gene expression.

Genome research·2001
Same author

A secondary drug resistance mutation of TEM-1 beta-lactamase that suppresses misfolding and aggregation.

Proceedings of the National Academy of Sciences of the United States of America·2000
Same journal

Structure of a human Rhinovirus complexed with its receptor molecule.

Protein engineering·2024
Same journal

pH-responsive polymer-assisted refolding of urea- and organic solvent-denatured alpha-chymotrypsin.

Protein engineering·2004
Same journal

Evaluation of different linker regions for multimerization and coupling chemistry for immobilization of a proteinaceous affinity ligand.

Protein engineering·2004
Same journal

Recombinant porcine intestinal carboxylesterase: cloning from the pig liver esterase gene by site-directed mutagenesis, functional expression and characterization.

Protein engineering·2004
Same journal

Periplasmic expression of human growth hormone via plasmid vectors containing the lambdaPL promoter: use of HPLC for product quantification.

Protein engineering·2004
Same journal

Shift of fibril-forming ability of the designed alpha-helical coiled-coil peptides into the physiological pH region.

Protein engineering·2004
See all related articles

Researchers identified a smaller peptide fragment of BLIP that effectively inhibits TEM-1 beta-lactamase. This 88% size reduction retains potent inhibitory activity, offering new avenues for drug design targeting beta-lactamase.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Drug Discovery

Background:

  • Protein-protein interactions are crucial for biological processes and drug development.
  • Small molecules mimicking protein inhibitor epitopes are of growing interest.
  • Bacterial inhibitor of protein A (BLIP) is a potent inhibitor of TEM-1 beta-lactamase.

Purpose of the Study:

  • To identify smaller peptide fragments of BLIP that retain inhibitory activity against TEM-1 beta-lactamase.
  • To develop novel, smaller inhibitors for beta-lactamase.

Main Methods:

  • Random fragmentation of the BLIP gene.
  • Phage display to isolate DNA segments encoding peptides that bind TEM-1 beta-lactamase.
  • Synthesis and binding analysis of identified peptide fragments.

Related Experiment Videos

Main Results:

  • A common, overlapping region (BLIP residues C30-D49) was identified in selected peptides.
  • The C30-D49 peptide fragment was synthesized and shown to inhibit TEM-1 beta-lactamase.
  • An 88% size reduction in BLIP resulted in a peptide that retains potent beta-lactamase inhibition.

Conclusions:

  • A significantly smaller peptide derivative of BLIP retains the ability to bind and inhibit TEM-1 beta-lactamase.
  • This finding supports the development of smaller, peptide-based inhibitors for beta-lactamase.
  • The study highlights the potential of epitope mapping for designing targeted therapeutics.